About Me

The chief goal of Alli Antar's research is to elucidate the mechanisms whereby specific genes impact metabolism, and, consequently, risk for obesity, type 2 diabetes, and cardiovascular disease. In graduate school at Vanderbilt University, with funding from the National Institutes of Health as well as the Lupus Foundation of America, Dr. Antar's reserach focused on the role of the enzyme 11beta-hydroxysteroid dehydrogenase type 1 in modulating lipid metabolism, as well as on its expression in and potential impact on the development of thymocytes. As a postdoctoral fellow, with the help of awards from the NIH, Alli Antar's research continued to focus on metabolism and impact of the immune system on the function of key metabolic tissues. Dr. Antar currently conducts research at Baylor College of Medicine and is actively involved in scientific societies that are both general in scope and specific to her field. In addition, Alli Antar also reviews manuscripts for several journals in her field and supervises and trains graduate and undergraduate students in the lab.